MAPT and Alzheimer disease: Serious motor deficits and reduction of spinal cord motor neurons, associated with neurogenic muscle atrophy and peripheral neuropathy, have been reported in mice with tau mutations at 4–6 months of age, while these symptoms are not observed in patients at early stages of AD [22–24] nor in our hTau368 mouse model.